Startup UroMems raises €14 million

UroMems, a startup founded in 2011 and housed at the BHT, has just completed a very impressive round of fundraising, bringing in €14 million in fresh capital. The company’s product—an artificial urinary sphincter implant that can be placed near the urethra—is a breakthrough innovation that could potentially help the 50 million people worldwide currently suffering from severe urinary incontinence.

The company’s technology is a better alternative than surgery, which often comes with serious side effects. It also features microsensors and processing electronics to adapt the implant to the patient’s physical activity in real time. UroMems tends to keep the details of its R&D under wraps, but does work closely with labs TIMC and TIMA.

Contact: hamid.lamraoui@uromems.com

Facebook

Twitter